Intro

In Episode 43 of Hims House, hosts Jonathan Stern and Patrick Lester (Bayside) sit down with Dr. William Seeds, a board-certified orthopedic surgeon and pioneer in peptide therapy. Dr. Seeds shares how a personal tragedy led him to explore the power of peptides and why he believes they will redefine the future of medicine. The conversation covers the fundamentals of peptides, why they are often called "magical" drugs, and the skepticism they sometimes face. The trio also explores why the U.S. lags behind Europe and Asia in adoption, and the historical influence of Big Pharma. The episode closes with Dr. Seeds sharing predictions on how Hims could legally enter the peptide market, what products they may launch first, and how the field will evolve over the next decade.

00:00 - Introduction

01:31 - Dr. Seeds’ personal journey into peptides

05:28 - Peptides 101

13:44 - Legal & Regulatory Barriers

17:00 - Response to Eric Topol's recent article

25:29 - The U.S. legal landscape

35:56 - Potential FDA crackdown bad actors

36:29 - Risks facing physicians and vendors

37:19 - What’s next in peptide policy

38:43 - Patents

40:51 - How Big Pharma shapes regulation

44:37 - Peptide adoption worldwide

47:06 - How will Hims enter the market?

56:45 - The two, five and ten-year outlook

01:02:55 - Final takeaways